Molecular Biology Reports

, Volume 46, Issue 4, pp 4213–4224 | Cite as

Induction of COX-1, suppression of COX-2 and pro-inflammatory cytokines gene expression by moringa leaves and its aqueous extract in aspirin-induced gastric ulcer rats

  • Hoda B. MabrokEmail author
  • Magda S. Mohamed
Original Article


The Moringa plant (Moringa oleifera) is known for its potential medicinal properties and health benefits in addition to its high nutritional value. The current study aimed to investigate the antiulcer effect of moringa leaves and its aqueous extract on pro-inflammatory cytokines and inflammatory mediators in ulcerative rats. Rats were treated with either moringa leaves (10%) or moringa extract (300 mg/kg body weight) for 4 weeks then treated with a single dose of aspirin to induce gastric ulcer. Moringa leaves and its extract markedly reduced ulcer index, gastric volume and total acidity. Both treatments induced a significant increase in gastric mucosal mucin content and plasma NO level associated with significant decrease in plasma TNFα. Moringa leaves and its extract prompted down-regulation of TNFα, TGFβ1 and COX2 genes expression by 2.7, 3.5, and 8.4 fold-change for moringa leaves and 2.7, and 2.3, 4.1 fold-change for moringa extract, respectively. Moringa leaves and extract treatments altered the COX-1 gene expression levels to near normal values. This study confirms the gastro-protective influence of moringa leaves and its extract on aspirin-induced ulcer in rats as manifested by its significant reduction in inflammatory cytokines and normalization of gastric mucosal mucin and NO level. Overall, moringa leaves powder is more efficient as antiulcer agent than moringa extract.


Moringa leaves Inflammatory cytokines Cyclooxygenase Mucin Nitric oxide Aspirin Ulcer 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Yap PR, Goh KL (2015) Non-steroidal anti-inflammatory drugs (NSAIDs) induced dyspepsia. Curr Pharm Des 21(35):5073–5081CrossRefPubMedGoogle Scholar
  2. 2.
    Zhang X, Tajima K, Kageyama K, Kyoi T (2008) Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats. World J Gastroenterol 14(30):4784–4790CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Takeuchi K (2012) Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility. World J Gastroenterol 18(18):2147–2160CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Abbas AM, Sakr HF (2013) Effect of selenium and grape seed extract on indomethacin-induced gastric ulcers in rats. J Physiol Biochem 69(3):527–537CrossRefPubMedGoogle Scholar
  5. 5.
    Peskar BM (2005) Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing. Inflammopharmacology 13(1–3):15–26CrossRefPubMedGoogle Scholar
  6. 6.
    Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, Evans J, O’Neill G (1996) Characterization of pros-taglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111:445–454CrossRefPubMedGoogle Scholar
  7. 7.
    Tanaka A, Araki H, Komoike Y, Hase S, Takeuchi K (2001) Inhibi-tion of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflamma-tory drugs. J Physiol Paris 95:21–27CrossRefPubMedGoogle Scholar
  8. 8.
    Tanaka A, Hase S, Miyazawa T, Takeuchi K (2002) Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage. J Pharmacol Exp Ther 300(3):754–761CrossRefPubMedGoogle Scholar
  9. 9.
    Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA (2009) Prostanoids in health and disease. J Lipid Res 50:S423–S428CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Takeuchi K, Tanaka A, Kato S, Amagase K, Satoh H (2010) Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Clin Chim Acta 411:459–466CrossRefPubMedGoogle Scholar
  11. 11.
    Sheng H, Shao J, Hooton EB, Tsujii M, DuBois RN, Beauchamp RD (1997) Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. Cell Growth Differ 8(4):463–470PubMedGoogle Scholar
  12. 12.
    Tominaga K, Arakawa T, Kim S, Iwao H, Kobayashi K (1997) Increased expression of transforming growth factor-b1 during gastric ulcer healing in rats. Dig Dis Sci 42:616–625CrossRefPubMedGoogle Scholar
  13. 13.
    Shih SC, Tseng KW, Lin SC, Kao CR, Chou SY, Wang HY, Chang WH, Chu CH, Wang TE, Chien CL (2005) Expression patterns of transforming growth factor-beta and its receptors in gastric mucosa of patients with refractory gastric ulcer. World J Gastroenterol 11(1):136–141CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Rahme E, Bardou M, Dasgupta K, Toubouti Y, Ghosn J, Barkun AN (2007) Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study. Rheumatology 46:265–272CrossRefPubMedGoogle Scholar
  15. 15.
    Kumar A, Ashwlayan V, Verma M (2019) Diagnostic approach & pharmacological treatment regimen of Peptic Ulcer Disease. Pharm Pharm Res Open Access J 1(1):1–12Google Scholar
  16. 16.
    Stillman MJ, Stillman MT (2007) Appropriate use of NSAIDs: considering cardiovascular risk in the elderly. Geriatrics 62:16–21PubMedGoogle Scholar
  17. 17.
    Roumie CL, Mitchel EF Jr, Kaltenbach L, Arbogast PG, Gideon P, Griffin MR (2008) Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke. Stroke 39:2037–2045CrossRefPubMedGoogle Scholar
  18. 18.
    Goyal B, Agrawal B, Goyal R, Mehta A (2007) Phytopharmacology of Moringa oleifera Lam.—an overview. Nat Prod Overv 6(4):347–353Google Scholar
  19. 19.
    Rockwood JL, Anderson BG, Casamatta DA (2013) Potential uses of Moringa oleifera and an examination of antibiotic efficacy conferred by M. oleifera seed and leaf extract using crude extraction techniques available to under-served indigenous populations. Int. J. Phytother Res 3:61–71Google Scholar
  20. 20.
    Kou X, Li B, Olayanju JB, Drake JM, Chen N (2018) Nutraceutical or pharmacological potential of Moringa oleifera Lam. Nutrients 10:343CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Bharali R, Tabassum J, Azad MRH (2003) Chemomodulatory effect of Moringa oleifera, Lam, on hepatic carcinogen metabolizing enzymes, antioxidant parameters and skin papillomagenesis in mice. Asian Pac J Cancer Prev 4:131–139PubMedGoogle Scholar
  22. 22.
    Choudhary MK, Bodakhe SH, Gupta SK (2013) Assessment of the antiulcer potential of Moringa oleifera root-bark extract in rats. J Acupunct Meridian Stud 6(4):214–220CrossRefPubMedGoogle Scholar
  23. 23.
    Kansara SS, Singhal M (2013) Evaluation of antiulcer activity of Moringa oleifera seed extract. JPSBR 3(1):20–25Google Scholar
  24. 24.
    Sahar BA, Abd El-Aal RAH (2015) The possible prophylactic effect of egyptian Moringa oleifera seed oil as anti-ulcer activity and anti-inflammatory in rats. J Biomed Pharm Res 4(6):01–09Google Scholar
  25. 25.
    Ijioma SN, Nwaogazi EN, Nwankwo AA, Oshilonya H, Ekeleme CM, Oshilonya LU (2018) Histological exhibition of the gastroprotective effect of Moringa oleifera leaf extract. Comp Clin Pathol 27:327–332CrossRefGoogle Scholar
  26. 26.
    Das D, Dash D, Mandal T, Kishore A, Bairy KL (2011) Protective effects of Moringa oleifera on experimentally induced gastric ulcers in rats. RJPBCS 2(2):50–55Google Scholar
  27. 27.
    Verma VK, Singh N, Saxena P, Singh R (2012) Anti-ulcer and antioxidant activity of Moringa oleifera (Lam) leaves against aspirin and ethanol induced gastric ulcer in rats. Int Res J Pharm 2(2):46–57Google Scholar
  28. 28.
    Hamid AK, Shariq B, Jiyauddin K, Kaleemullah M, Samer AD, Sakina R, Rasha S (2015) Anti-ulcer activity of Moringa oleifera leave’s extract in swiss albino mice against aspirin induced peptic ulcer. World J Pharm Res 4(5):406–421Google Scholar
  29. 29.
    Almuzafar HM (2018) Effect of Moringa oleifera leaves extract on the oxidative stress and gastric mucosal ulcer induced by indomethacin in rats. Afr J Biotechnol 17(3):51–56CrossRefGoogle Scholar
  30. 30.
    Olaibi OK, Ijomone OM, Olawuni IJ, Adewole SO, Akinsomisoye SO (2014) Mucus secreting activity and nitric oxide concentrations of ethanol-injured pylorus and duodenum of rats pretreated with Moringa oleifera. J Exp Integr Med 4(2):123–130CrossRefGoogle Scholar
  31. 31.
    Adugba A, Eke B, Onahinon C, Ibu J, Eru E, Akwaras DN, Saalu L, Ibu J (2018) Moringa oleifera causes gastro protection on acid-alcohol induced ulcer. IOSR J Dent Med Sci 17(7):44–49Google Scholar
  32. 32.
    López M, Ríos-Silva M, Huerta M, Cárdenas Y, Bricio-Barrios JA, Díaz-Reval MI, Urzúa Z, Huerta-Trujillo M, López-Quezada K, Trujillo X (2018) Effects of Moringa oleifera leaf powder on metabolic syndrome induced in male Wistar rats: a preliminary study. J Int Med Res 46(8):3327–3336CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Helmy SA, Morsy NFS, Elaby SM, Ghaly MAA (2017) Hypolipidemic effect of Moringa oleifera lam leaf powder and its extract in diet-induced hypercholesterolemic Rats. J Med Food 20(8):755–762CrossRefPubMedGoogle Scholar
  34. 34.
    Idohou-Dossou N, Diouf A, Gueye AL, Guiro AT, Wade (2011) Impact of daily consumption of moringa dry leaf powder on iron status of senegalese lactating women. AJFAND 11(4):4985–4999CrossRefGoogle Scholar
  35. 35.
    Tshingani K, Donnen P, Mukumbi H, Duez P, Dramaix-Wilmet M (2017) Impact of Moringa oleifera lam. Leaf powder supplementation versus nutritional counseling on the body mass index and immune response of HIV patients on antiretroviral therapy: a single-blind randomized control trial. BMC Compl Altern Med 17:420CrossRefGoogle Scholar
  36. 36.
    Saeedeh A, Asna U (2007) Antioxidant properties of various solvent extracts of mulberry (Morus indica L) leaves. Food Chem 102:1233–1240CrossRefGoogle Scholar
  37. 37.
    Ordon JD, Gomez MA, Vattuone MI (2006) Antioxidant activities of Sechium edule (jacq.)Swartz extracts. Food Chem 97:452–458CrossRefGoogle Scholar
  38. 38.
    Lee SC, Kim JH, Jeong SM, Kim DR, Ha JU, Nam KC (2003) Effect of far-infrared radiation on the antioxidant activity of rice hulls. J Agric Food Chem 51:4400–4403CrossRefPubMedGoogle Scholar
  39. 39.
    Kim KH, Tsao R, Yang R, Cui SW (2006) Phenolic acid profiles and antioxidant activities of wheat bran extracts and the effect of hydrolysis conditions. Food Chem 95:466–473CrossRefGoogle Scholar
  40. 40.
    Reeves PG, Nielsen FH, Fahey GCJR (1993) AIN-93 purified diets for laboratory rodents: final report of the american institute of nutrition ad. hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939–1951CrossRefPubMedGoogle Scholar
  41. 41.
    Zoobi J, Mohd A (2011) Evaluation of antiulcer activity of the flowers of punica granatum experimental animals. Int J Res Ayurveda Pharm 2(4):1210–1213Google Scholar
  42. 42.
    Amjad M, Tahir M (2017) Effect of ethanolic extract of coconut (Cocos nucifera) on aspirin-induced gastric ulcer in albino rats. J Gastrointest Dig Syst 7(3):1–6Google Scholar
  43. 43.
    Montgomery HAC, Dymock JF (1961) The determination of nitrate in water. Analyst 86:414–416Google Scholar
  44. 44.
    Stepaniak JA, Gould KE, Sun D, Swanborg RH (1995) A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. J Immunol 155(5):2762–2769PubMedGoogle Scholar
  45. 45.
    Arige SD, Rao L (2017) A review on pharmacological screening of anti ulcer agents. Int J Med Lab Res 2(3):44–54Google Scholar
  46. 46.
    Corne SJ, Morrissey SM, Woods RJ (1974) Proceedings: a method for the quantitative estimation of gastric barrier mucus. J Physiol 242(2):116P–117PPubMedGoogle Scholar
  47. 47.
    Mowry RW (1956) Alcian blue technics for the histochemical properties of rodent acid mucopolysaccharides. J Hist Cytochem 4:407Google Scholar
  48. 48.
    Mabrok HB, Klopfleisch R, Ghanem KZ, Clavel T, Blaut M, Loh G (2012) Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis 33(1):203–208CrossRefPubMedGoogle Scholar
  49. 49.
    Li RC, Row BW, Gozal E, Kheirandish L, Fan Q, Brittian KR, Guo SZ, Sachleben LR Jr, Gozal D (2003) Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat. Am J Respir Crit Care Med 168:469–475CrossRefPubMedGoogle Scholar
  50. 50.
    Ryu SH, Chung YH, Lee JK, Kim JA, Shin JW, Jang MK, Park NH, Lee HC, Lee YS, Suh DJ (2009) Antifibrogenic effects of tamoxifen in a rat model of periportal hepatic fibrosis. Liver Int 29(2):308–314CrossRefPubMedGoogle Scholar
  51. 51.
    Khan HA, Abdelhalim MAK, Alhomida AS, Al-Ayed MS (2013) Transient increase in IL-1β, IL-6 and TNF-α gene expression in rat liver exposed to gold nanoparticles. Genet Mol Res 12(4):5851–5857CrossRefPubMedGoogle Scholar
  52. 52.
    Chun JM, Kim HS, Lee AY, Kim S, Kim HK (2016) Anti-inflammatory and antiosteoarthritis effects of Saposhnikovia divaricata ethanol extract: in vitro and in vivo studies. Evid Based Compl Altern Med 2016:1–8CrossRefGoogle Scholar
  53. 53.
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2–ΔΔCt method. Methods 25:402–408CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284:1247–1255CrossRefPubMedGoogle Scholar
  55. 55.
    Vinothapooshan G, Sundar K (2010) Anti-ulcer activity of Mimosa pudica leaves against gastric ulcer in rats. Res J Pharm Biol Chem Sci 1:606–614Google Scholar
  56. 56.
    Funatsu T, Chono K, Hirata T, Keto Y, Kimoto A, Sasamata M (2007) Mucosal acid causes gastric mucosal microcirculatory disturbance in nonsteroidal anti-inflammatory drug-treated rats. Eur J Pharmacol 554:53–59CrossRefPubMedGoogle Scholar
  57. 57.
    Baumgartner HK, Starodub OT, Joehl JS, Tackett L, Montrose MH (2004) Cyclooxygenase 1 is required for pH control at the mouse gastric surface. Gut 53:1751–1757CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Jainu M, Mohan KV, Devi CSS (2006) Gastroprotective effect of Cissus quadrangularis extract in rats with experimentally induced ulcer. Indian J Med Res 123:799–806PubMedGoogle Scholar
  59. 59.
    Thamotharan G, Sekar G, Ganesh T, Sen S, Chakraborty R, Kumar S (2010) Antiulcerogenic effects of Lantana camara Linn. leaves on in vivo test models in rats. Asian J Pharm Clin Res 3:57–60Google Scholar
  60. 60.
    Mizuno H, Akamatsu T, Kasuga M (1997) Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112:387–397CrossRefPubMedGoogle Scholar
  61. 61.
    Zhang CX, Guo LK, Guo XF (2015) Interaction between the poly-morphisms of cyclooxygenase-2-1195G/A, MnSOD9Ala/val genes and the high-fat diets and its correlation with ulcerative colitis. Chin Acad Med Sci 37:37–43Google Scholar
  62. 62.
    Musumba C, Pritchard DM, Pirmohamed M (2009) Review article: cellular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment Pharmacol Ther 30:517–531CrossRefPubMedGoogle Scholar
  63. 63.
    Gretzer B, Maricic N, Respondek M, Schuligoi R, Peskar BM (2001) Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 132:1565–1573CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Davies NM, Sharkey KA, Asfaha S, Macnaughton WK, Wallace JL (1997) Aspirin causes rapid up-regulation of cyclo-oxygenase-2 expression in the stomach of rats. Aliment Pharmacol Ther 11:1101–1108CrossRefPubMedGoogle Scholar
  65. 65.
    Tóth L, Muszbek L, Komáromi I (2013) Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations. J Mol Gr Model 40:99–109CrossRefGoogle Scholar
  66. 66.
    Wallace JL, McKnight W, Reuter BK, Vergnolle N (2000) NSAID induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroeneterology 119:706–714CrossRefGoogle Scholar
  67. 67.
    Schmassmann A, Zoidl G, Peskar BM, Waser B, Schmassmann-Suhijar D, Gebbers JO, Reubi JC (2006) Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice. Am J Physiol Gastrointest Liver Physiol 290:G747–G756CrossRefPubMedGoogle Scholar
  68. 68.
    Magierowski M, Magierowska K, Kwiecien S, Brzozowski T (2015) Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healing. Molecules 20:9099–9123CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Salvemini D, Kim SF, Mollace V (2013) Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications. Am J Physiol Regul Integr Comp Physiol 304(7):R473–R487CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Wang QS, Cui YL, Dong TJ, Zhang XF, Lin KM (2012) Ethanol extract from a Chinese herbal formula, “Zuojin Pill”, inhibit the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 mouse macrophages. J Ethnopharmacol 141:377–385CrossRefPubMedGoogle Scholar
  71. 71.
    Nahar PP, Driscoll MV, Li L, Slitt AL, Seeram NP (2014) Phenolic mediated anti-inflammatory properties of a maple syrup extract in RAW 264.7 murine macrophages. J Funct Foods 6:126–136CrossRefGoogle Scholar
  72. 72.
    Wallace JL, Miller MJS (2000) Nitric oxide in mucosal defense. A little goes a long-way. Gastroenterology 119:512–520CrossRefPubMedGoogle Scholar
  73. 73.
    Motawi TK, Abd Elgawad HM, Shahin NN (2007) Modulation of indomethacin-induced gastric injury by spermine and taurine in rats. J Biochem Mol Toxicol 21:280–288CrossRefPubMedGoogle Scholar
  74. 74.
    Ma L, Wallace JL (2000) Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. Am J Physiol Gastrointest Liver Physiol 279:G341–G346CrossRefPubMedGoogle Scholar
  75. 75.
    Okereke CJ, Akaninwor JO (2013) The protein quality of raw leaf, seed and root of Moringa oleifera grown in Rivers State. Niger Ann Biol Res 4(11):34–38Google Scholar
  76. 76.
    Santucci L, Fiorucci S, Di Matteo FM (1995) Role of tumor necrosis factor 31 release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology 108:393–401CrossRefPubMedGoogle Scholar
  77. 77.
    Jambi HA, Khattab HAH (2019) Potential antioxidant, anti-inflammatory and gastroprotective effect of grape seed extract in indomethacin-induced gastric ulcer in rats. Int J Pharmacol 15:209–218CrossRefGoogle Scholar
  78. 78.
    Verma S, Kumar VL (2016) Attenuation of gastric mucosal damage by artesunate in rat: modulation of oxidative stress and NFκB mediated signaling. Chem Biol Interact 257:46–53CrossRefPubMedGoogle Scholar
  79. 79.
    Yang Y, Yin B, Lv L, Wang Z, He J, Chen Z, Wen X, Zhang Y, Sun W, Li Y, Zhao Y (2017) Gastroprotective effect of aucubin against ethanol-induced gastric mucosal injury in mice. Life Sci 189:44–51CrossRefPubMedGoogle Scholar
  80. 80.
    Brzozowska I, Targosz A, Sliwowski Z, Kwiecien S, Drozdowicz D, Pajdo R, Konturek PC, Brzozowski T, Pawlik M, Konturek SJ, Pawlik WW, Hahn EG (2004) Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor. J Pharm Pharmacol 55:773–790Google Scholar
  81. 81.
    Oyewo EB, Adetutu A, Ayoade A, Akanji MA (2013) Repeated oral administration of aqueous leaf extract of Moringa oleifera modulated immunoactivities in Wistar Rats. J Nat Sci Res 3(6):100–109Google Scholar
  82. 82.
    Shang P, Liu W, Liu T, Zhang Y, Mu F, Zhu Z, Liang L, Zhai X, Ding Y, Li Y, Wen A (2016) Acetyl-11-keto-β-boswellic acid attenuates prooxidant and profibrotic mechanisms involving transforming growth factor-β1, and improves vascular remodeling in spontaneously hypertensive rats. Sci Rep 6(1):39809CrossRefPubMedPubMedCentralGoogle Scholar
  83. 83.
    Takahashi S, Shigeta J, Inoue H, Tanabe T, Okabe S (1998) Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats. Am J Physiol 275:G1137–G1145PubMedGoogle Scholar
  84. 84.
    Takahashi S, Kobayashi N, Okabe S (1999) Regulation by endogenous interleukin-1 of mrna expression of healing-related factors in gastric ulcers in rats. J Pharmacol Exp Ther 291(2):634–640CrossRefPubMedGoogle Scholar
  85. 85.
    Shih SC, Chien CL, Tseng KW, Lin SC, Kao CR (1999) Immunohistochemical studies of transforming growth factor-beta and its receptors in the gastric mucosa of patients with refractory gastric ulcer. J Formos Med Assoc 98:613–620PubMedGoogle Scholar
  86. 86.
    Wu MS, Lin JT, Hsu PN, Lin CY, Hsieh YT, Chiu YH, Hsueh PR, Liao KW (2007) Preferential induction of transforming growth factor-beta production in gastric epithelial cells and monocytes by Helicobacter pylori soluble proteins. J Infect Dis 196:1386–1393CrossRefPubMedGoogle Scholar
  87. 87.
    Ernst H, Konturek PC, Brzozowski T, Konturek SJ, Hahn EG (1996) Subserosal application of transforming growth factor-beta 1 in rats with chronic gastric ulcers: effect on gastric ulcer healing and blood flow. J Physiol Pharmacol 47:443–454PubMedGoogle Scholar
  88. 88.
    Gopalakrishnanb L, Doriyaa K, Kumara DS (2016) Moringa oleifera: a review on nutritive importance and its medicinal application. Food Sci Hum Wellness 5:49–56CrossRefGoogle Scholar
  89. 89.
    La Casa C, Villegas I, Alarcón de la Lastra C, Motilva V, Martín Calero MJ (2000) Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J Ethnopharmacol 71:45–53CrossRefPubMedGoogle Scholar
  90. 90.
    Birto SA, de Almeida CLF, de Santana TI et al (2018) Antiulcer activity and potential mechanism of action of the leaves of Spondias mombin L. Oxid Med Cell Longev 2018:1–20CrossRefGoogle Scholar
  91. 91.
    Shimoyama AT, Santin JR, Machado ID, deOliveirae-Silva AM, de Melo IL, Mancini-Filho J, Farsky SH (2013) Antiulcerogenic activity of chlorogenic acid in different models of gastric ulcer. Naunyn Schmiedebergs Arch Pharmacol 386(1):5–14CrossRefPubMedGoogle Scholar
  92. 92.
    de Souza MO, Sérgio-Gushiken LF, Beserra FP, Pellizzon CH (2017) Evaluation of the gastroprotective and antioxidant effects of caffeine and caffeic acid on ethanol-induced gastric ulcer. JSM Hepat 2(1):1008Google Scholar
  93. 93.
    Altinoz MA, Elmaci İ, Ozpinar A (2018) Gentisic acid, a quinonoid aspirin metabolite in cancer prevention and treatment. New horizons in management of brain tumors and systemic cancers. J Cancer Res Oncobiol 1(2):1–19Google Scholar
  94. 94.
    Meyer K, Ragan C (1948) The antirheumatic effect of sodium gentisate. Science 108(2802):281CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Food Industry and Nutrition Division, Nutrition and Food Science DepartmentNational Research CentreCairoEgypt

Personalised recommendations